Paracetamol + Mefenamic AcidThird Party Manufacturing in India

Paracetamol + Mefenamic Acid is a fixed-dose combination that delivers complementary analgesic and anti-inflammatory effects through two distinct mechanisms, providing superior pain relief compared to either agent alone.

Paracetamol produces analgesia and antipyresis primarily through central nervous system mechanisms. It inhibits cyclooxygenase enzymes, particularly COX-2, in the brain, reducing prostaglandin synthesis in the hypothalamic thermoregulatory center and pain-processing pathways. Paracetamol also modulates the serotonergic descending inhibitory pathways and activates cannabinoid receptors to some degree. It has negligible peripheral anti-inflammatory activity, which makes it an ideal partner for an NSAID like mefenamic acid.

Mefenamic Acid belongs to the fenamate class of non-steroidal anti-inflammatory drugs. It competitively and reversibly inhibits both COX-1 and COX-2 enzymes, blocking the conversion of arachidonic acid to prostaglandins and thromboxanes at the site of inflammation. This peripheral anti-inflammatory action complements paracetamol's central analgesic effect. Additionally, mefenamic acid antagonizes certain prostaglandin receptors directly and may modulate GABA-A receptors, contributing to its analgesic profile. Unlike some NSAIDs, mefenamic acid demonstrates particularly effective antiprostaglandin activity in inflammatory exudates.

The combination provides balanced central and peripheral pain control, making it effective for conditions involving both pain and inflammation. The dual mechanism allows for lower individual doses while achieving enhanced therapeutic outcomes, particularly in dysmenorrhoea, musculoskeletal pain, and dental pain.

Therapeutic Uses

Paracetamol + Mefenamic Acid combination is prescribed for the management of mild to moderate pain where both analgesia and anti-inflammatory action are required. Clinical indications include:

• Primary Dysmenorrhoea: Highly effective for painful menstrual cramps due to mefenamic acid's potent anti-prostaglandin activity in uterine tissue, combined with paracetamol's central analgesic effect.
• Dental Pain: Provides relief from odontogenic pain including post-extraction pain and dental abscess discomfort where inflammation is a significant component.
• Musculoskeletal Pain: Used in acute and subacute conditions including low back pain, myalgia, sprains, and strains where both pain and inflammation need management.
• Headache: Effective for tension-type headaches and migraine-associated pain where NSAID therapy is appropriate.
• Post-traumatic Inflammation: Reduces pain and swelling following minor injuries including contusions and soft tissue trauma.
• Fever with Body Ache: Offers antipyretic action alongside relief from generalized body aches during febrile illness.

Why Manufacturers Choose Paracetamol + Mefenamic Acid

This combination is one of the most prescribed analgesic formulations in the Indian domestic market, particularly for gynaecological and dental pain management. Both active ingredients are well-established molecules with extensive safety data, predictable pharmacokinetics, and proven manufacturing processes.

Indian manufacturers produce this combination at both standard and pediatric strengths, serving a broad demographic. The availability of paracetamol and mefenamic acid APIs from multiple domestic suppliers ensures cost-competitive production. The formulation is compatible with standard tablet manufacturing technologies including wet granulation and direct compression.

This combination presents an attractive opportunity for PCD franchise partners targeting the gynaecology, dental, and general practice segments. Consistent demand from institutional buyers, government tenders, and export markets to Africa and Asia makes Paracetamol + Mefenamic Acid a reliable volume driver for third party manufacturing in India.